- Core C (Computational Core) The DNA and RNA next generation sequencing and experimental data generated by Projects 1 ? 3 require trained bioinformaticians to process the data and conduct the downstream analysis to help the project investigators interpret the results and identify target genes for validation. Over the past years, the Computational Core has developed an infrastructure with powerful computing clusters, storage space, and well-established software to conduct the computations required. We have also been working closely with Project 1 and Core B (Preclinical Therapeutics Core) investigators to develop and improve the algorithms for tracking molecular barcodes in vivo in order to to accurately evaluate genes for their tumor initiating potentials and to identify targets for clinical treatments of pancreatic ductal adenocarcinoma. The following three specific aims are proposed: 1. One significant contribution the Computational Core can make is to conduct integrative analysis leveraging readily available MDACC internal patients and external public data sources to seek for answers, formulate hypothesis, and validate the experimental results with dedicated computational biologists. We will mine the private and public databases to provide information needed to guide the experiments and the validation of the experimental results. Databases or archives containing data collected from TCGA, CCLE, COSMIC, and MD Anderson Cancer Center's patient data repositories have been built with interfaces and applications to facilitate exploration, and visualization have been developed. Data mining results will be communicated with project investigators. 2. We will provide P01 investigators with statistical analysis of RNASeq gene expression data to identify differentially expressed genes between genomic groups, disease subtypes, or treatment conditions to identify biomarkers. A collection of publically available and internally developed tools have been configured to run on the computing cluster that can be selected based on the nature of the experiment and data structure. We will also further improve the algorithm we have developed for in vivo screening projects to identify genes as potential targets of treatments. 3. We will process the next generation sequencing data following established standards and implement quality control measures at each step to produce high quality data that can be used for downstream analysis to identify target genes with clinical implications. A production level infrastructure has been established to ensure the achievement of this goal.

Public Health Relevance

? Core C (Computational Core) The Computational Core conducts integrative analysis leveraging the readily available MDACC internal patient and the external public data sources to seek answers, formulate hypothesis, and validate experimental results of this PDAC P01. Results will help to provide insights into potential combination therapies for this deadly disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA117969-15
Application #
9904489
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
15
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Lundquist, Mark R; Goncalves, Marcus D; Loughran, Ryan M et al. (2018) Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating Autophagy. Mol Cell 70:531-544.e9
Hopkins, Benjamin D; Pauli, Chantal; Du, Xing et al. (2018) Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature 560:499-503
Biancur, Douglas E; Kimmelman, Alec C (2018) The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance. Biochim Biophys Acta Rev Cancer 1870:67-75
Chen, Yang; LeBleu, Valerie S; Carstens, Julienne L et al. (2018) Dual reporter genetic mouse models of pancreatic cancer identify an epithelial-to-mesenchymal transition-independent metastasis program. EMBO Mol Med 10:
Hill, Margaret A; Alexander, William B; Guo, Bing et al. (2018) Kras and Tp53 Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma. Cancer Res 78:4445-4451
Mendt, Mayela; Kamerkar, Sushrut; Sugimoto, Hikaru et al. (2018) Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight 3:
Patra, Krushna C; Kato, Yasutaka; Mizukami, Yusuke et al. (2018) Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism. Nat Cell Biol 20:811-822
Anglin, Justin; Zavareh, Reza Beheshti; Sander, Philipp N et al. (2018) Discovery and optimization of aspartate aminotransferase 1 inhibitors to target redox balance in pancreatic ductal adenocarcinoma. Bioorg Med Chem Lett 28:2675-2678
Yang, Annan; Herter-Sprie, Grit; Zhang, Haikuo et al. (2018) Autophagy Sustains Pancreatic Cancer Growth through Both Cell-Autonomous and Nonautonomous Mechanisms. Cancer Discov 8:276-287
Santana-Codina, Naiara; Roeth, Anjali A; Zhang, Yi et al. (2018) Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis. Nat Commun 9:4945

Showing the most recent 10 out of 134 publications